VPG LaserOne participated in the Interdisciplinary Urology Care Consortium (IUCC 2025), held on 17–18 May 2025 in Dubai, bringing together nearly 600 healthcare professionals, 80 international speakers, and representatives from 25 countries. The event served as a key platform for advancing knowledge and fostering collaboration in modern urology.
As the Diamond Sponsor of IUCC 2025, VPG LaserOne demonstrated its commitment to supporting clinical education, innovation, and the advancement of minimally invasive treatment technologies. The company was prominently represented throughout the scientific and exhibition programs.
Expert Perspectives on Clinical Innovation
Moderated by Dr. Yasser Farahat, the workshop brought together industry and clinical experts to discuss the latest advances in thulium fiber laser technology. Viktoria Andreeva presented VPG LaserOne's technology vision and laser platform portfolio, while Dr. Amr Elsawy, MD, PhD, FEBU, and Dr. Ayman Asem shared their clinical experience using thulium fiber laser systems at Sheikh Khalifa Hospitals in the UAE.
Advanced TFL technologies for modern urology
The scientific program also featured presentations by internationally recognized experts. Prof. Alexey Martov presented "Thulium Fiber Laser Lithotripsy Using a New Advanced Fragmentation Pulse," highlighting the clinical potential of advanced pulse technologies for enhanced stone fragmentation. Prof. Alim Dymov presented "ThuFLEP with Special Enucleation Pulse: A New Opportunity," demonstrating the latest advances in thulium fiber laser applications for benign prostatic hyperplasia (BPH) treatment.
Beyond the scientific sessions, attendees had the opportunity to experience Urolase Max and UVS through hands-on simulations. The interactive demonstrations allowed participants to evaluate the system's precision, control, and safety features in realistic procedural scenarios.
The program also featured semi-live surgery sessions showcasing VPG LaserOne technologies in clinical practice. Prof. Alim Dymov demonstrated TFL BPH Enucleation, while Prof. Alexey Martov presented TFL Lithotripsy with the unique Tissue Sensor safety feature. These sessions provided attendees with practical insights into laser-tissue interaction, surgical techniques, and the clinical benefits of next-generation thulium fiber laser systems.
Driving innovation in endourology
From advanced energy control and optimized fragmentation modes to enhanced safety features and precise tissue interaction, VPG LaserOne's technologies demonstrated their potential to address the evolving needs of modern endourology. The strong engagement from attendees reflected growing interest in next-generation thulium fiber laser solutions that support improved surgical outcomes and clinical efficiency.
Setting new standards in endourology
From advanced energy control to enhanced tissue interaction and safety mechanisms, VPG LaserOne's technologies demonstrated their ability to address the evolving needs of endourology. The strong engagement from attendees reaffirmed the growing interest in next-generation thulium fiber laser solutions that support greater precision, efficiency, and patient outcomes.
Strong engagement from the global urology community
IUCC 2025 attracted specialists from across the Middle East, Europe, and Asia, creating valuable opportunities for knowledge exchange and discussion. VPG LaserOne engaged with healthcare professionals, key opinion leaders, and industry partners throughout the event.
The successful participation at IUCC 2025 further strengthened VPG LaserOne's position as a leader in thulium fiber laser technology and reaffirmed the company's commitment to developing innovative solutions that improve patient outcomes and support the evolution of modern urology.
